Nail Loss After Teriflunomide Treatment: A New Potential Adverse Event
September 2017
in “
Multiple Sclerosis and Related Disorders
”
Studysummary This study suggests that nail loss may be a new, reversible adverse event related to teriflunomide treatment, akin to its known effects on hair loss.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on msard-journal.com →